Sangamo Biosciences (SGMO) 17.55 $SGMO Sangamo
Post# of 64200
Posted On: 03/08/2015 6:09:01 PM
Sangamo Biosciences (SGMO) 17.55 $SGMO
Sangamo Biosciences (SGMO) is in Overbought Territory: What's Next? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 6:14AM CST
Sangamo Biosciences (SGMO) is in Overbought Territory: What’s Next?
SGMO: 17.55 (-0.51)
Strong On High Volume: Sangamo BioSciences (SGMO)
at The Street - Mon Mar 02, 9:02AM CST
Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a strong on high relative volume candidate
SGMO: 17.55 (-0.51)
Biogen's hemophilia B med successful in Phase 3 trial in children
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 8:59AM CST
BIIB: 417.63 (-7.98), ALNY: 107.67 (-3.89), OPK: 14.11 (-0.21), ONCE: 58.01 (+0.48), BAX: 67.73 (-1.48), SHPG: 235.75 (-2.31), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51)
The Top Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 22, 2:51AM CST
GFIG: 5.83 (+0.11), MATW: 46.36 (-1.03), RTIX: 5.32 (-0.03), ELLI: 51.40 (-0.66), KFRC: 22.15 (-0.23), SILC: 45.43 (+0.17), SGMO: 17.55 (-0.51), AFFX: 11.81 (-0.38), BABY: 35.54 (-0.45), HBIO: 5.58 (+0.07), EXAM: 39.64 (-0.06), IART: 59.15 (-0.96), UEIC: 55.16 (-0.70), CNMD: 50.44 (-0.98), BJRI: 51.63 (-0.88), NLNK: 48.65 (-0.28), CTRN: 25.74 (-0.47), ANAC: 47.18 (+0.36), CSU: 24.90 (-0.46), RRGB: 78.48 (-3.35), DIOD: 28.32 (+0.06), DEPO: 23.44 (-0.77), DYAX: 15.64 (-0.05), FARO: 53.91 (-2.22), PERY: 22.62 (-0.69), PACB: 6.17 (-0.22), PFPT: 55.39 (-1.50), MTSI: 33.21 (-0.61), IRWD: 15.81 (+0.04), ABAX: 62.39 (+0.24), SCSS: 31.82 (-0.39), ANIP: 66.72 (+0.21), FORM: 9.01 (-0.19), BEAT: 10.31 (-0.33), QLGC: 14.88 (-0.08), PENX: 18.84 (unch), EBIX: 25.17 (-0.20), CORT: 3.42 (-0.19), UTMD: 59.52 (-0.56), DAVE: 31.17 (-0.45), SWHC: 14.23 (-0.17)
Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), CVM: 1.06 (-0.08), MDGN: 8.35 (+0.17), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), RPRX: 9.84 (-0.01), MNKD: 5.47 (-0.26), CELG: 118.03 (-2.68), SGEN: 35.32 (-0.28), TEVA: 56.40 (-0.11), ARIA: 8.08 (-0.17), SNY: 47.42 (-0.94), REGN: 422.13 (-6.82)
Insider Trading Alert - ABMD, CCMP And SGMO Traded By Insiders
at The Street - Thu Feb 19, 10:15AM CST
Stocks with insider trader activity include ABMD, CCMP and SGMO
ABMD: 60.35 (-1.03), SGMO: 17.55 (-0.51), CCMP: 50.13 (-0.58)
Makers of pricey drugs working on new payment model
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 9:10AM CST
ABT: 46.50 (-0.94), BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), AMGN: 154.88 (-4.72), LLY: 68.41 (-2.18), BMY: 65.12 (-0.93), GSK: 46.73 (-0.87), CELG: 118.03 (-2.68), JNJ: 100.11 (-2.41), QURE: 24.62 (+1.77), GILD: 101.81 (-1.61), BAX: 67.73 (-1.48), MRK: 56.84 (-1.14), AZN: 66.27 (-1.91), NVS: 97.46 (-1.49)
A Look at the Latest Occurrences in the Healthcare Sector: Special Research on Sangamo BioSciences,Seattle Genetics, StemCells, Synageva and VBI Vaccines
PR Newswire - Thu Feb 19, 6:50AM CST
Editor Note: For more information about this release, please scroll to bottom.
GEVA: 103.20 (+1.96), SGEN: 35.32 (-0.28), STEM: 1.23 (-0.06), SGMO: 17.55 (-0.51), VBIV: 2.98 (+0.07)
Sangamo BioSciences - Gene Therapy To Invest In
Samreen Agha - at Seeking Alpha - Wed Feb 18, 11:55AM CST
SGMO: 17.55 (-0.51)
3 Stocks That Were Huge Winners Last Week
Todd Campbell, The Motley Fool - Motley Fool - Sat Feb 14, 11:29AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. The market's best-performing companies last week included...
JNJ: 100.11 (-2.41), BIIB: 417.63 (-7.98), PTLA: 41.72 (-0.13), SHPG: 235.75 (-2.31), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), BMY: 65.12 (-0.93), MOH: 61.27 (-1.00)
Sangamo BioSciences Presents Data At 11th Annual WorldSymposium(TM) Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders
PR Newswire - Thu Feb 12, 6:00AM CST
Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the presentation of preclinical data from its In Vivo Protein Replacement Platform (IVPRP) program for the development of proprietary ZFP Therapeutics® for the potential cure of lysosomal storage disorders (LSDs). The study was presented at the WORLDSymposium(TM) 2015 Meeting, a multidisciplinary forum presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases, which is being held in Orlando, Florida, from February 9-13, 2015. The data were generated by Sangamo scientists and their collaborators at the University of Minnesota and University of Massachusetts Medical School.
SGMO: 17.55 (-0.51)
4 Stocks Spiking on Big Volume: Akamai, Hydrogenics and More
at The Street - Wed Feb 11, 1:11PM CST
Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
HYGS: 14.82 (+0.04), AKAM: 69.96 (-1.13), SGMO: 17.55 (-0.51), FTI: 38.84 (-0.65)
Why Sangamo Biosciences Inc. Shares Rocketed Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Feb 11, 11:58AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Sangamo Biosciences shares surged more than 14%...
BIIB: 417.63 (-7.98), SHPG: 235.75 (-2.31), SGMO: 17.55 (-0.51)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 11:45AM CST
JIVE: 5.01 (-0.02), JONE: 8.68 (+0.26), FXEN: 1.83 (-0.03), CDTI: 1.98 (-0.02), SGMO: 17.55 (-0.51), EVRY: 1.00 (unch), INXN: 29.87 (-0.21), RLOC: 2.98 (-0.02), ATEN: 4.33 (-0.11), BLDP: 2.29 (-0.06), PNTR: 8.85 (+0.06), PRSS: 3.48 (-0.02), BXE: 2.99 (-0.06), ANTH: 6.12 (+0.59), PIR: 11.96 (-0.09), PSTR: 3.58 (-0.17), MKTO: 26.56 (-0.42), ANDE: 42.11 (-3.25), DGLY: 12.81 (+0.43), DCTH: 1.16 (+0.02)
Sangamo BioSciences ups revenues 117% in Q4
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:55AM CST
SGMO: 17.55 (-0.51)
Sangamo Biosciences' (SGMO) CEO Edward Lanphieron Q4 2014Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 10, 6:56PM CST
SGMO: 17.55 (-0.51)
Sangamo BioSciences (SGMO) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 10, 3:55PM CST
SGMO: 17.55 (-0.51)
Sangamo BioSciences beats by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:05PM CST
SGMO: 17.55 (-0.51)
Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results
PR Newswire - Tue Feb 10, 3:02PM CST
Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its fourth quarter and full year 2014 financial results and accomplishments.
SGMO: 17.55 (-0.51)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 4:35PM CST
SGMO: 17.55 (-0.51), USNA: 98.80 (-0.77), RLOC: 2.98 (-0.02), ATEN: 4.33 (-0.11), VSAT: 64.50 (-0.25), RPXC: 14.23 (-0.06), TRMB: 26.10 (-0.25), KGC: 2.51 (-0.24), WSH: 47.21 (-0.56), TSRA: 39.92 (+0.26), FTI: 38.84 (-0.65), ACGL: 59.87 (-0.04), LOCK: 13.21 (-0.32), CERN: 69.97 (-2.54), CAP: 23.99 (-0.09), JIVE: 5.01 (-0.02), WU: 19.45 (-0.04), AKAM: 69.96 (-1.13), SKT: 34.13 (-0.92), NCR: 28.77 (-0.39), FRT: 137.11 (-4.74), SCI: 25.21 (-0.07), ELON: 1.16 (-0.01), GNW: 7.67 (+0.06), RKUS: 12.35 (-0.17), GHDX: 32.01 (-0.32), BLKB: 45.07 (-0.09), PXD: 156.17 (-4.27), SGEN: 35.32 (-0.28), OHI: 38.02 (-1.99), THOR: 39.50 (-0.83), MKTO: 26.56 (-0.42), CRL: 76.77 (-0.93), TMH: 57.11 (-1.15), ANDE: 42.11 (-3.25), XOOM: 16.09 (-0.37), HIW: 43.31 (-1.65), PAYC: 32.16 (-0.19)
Sangamo Biosciences (SGMO) is in Overbought Territory: What's Next? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Mar 03, 6:14AM CST
Sangamo Biosciences (SGMO) is in Overbought Territory: What’s Next?
SGMO: 17.55 (-0.51)
Strong On High Volume: Sangamo BioSciences (SGMO)
at The Street - Mon Mar 02, 9:02AM CST
Trade-Ideas LLC identified Sangamo BioSciences (SGMO) as a strong on high relative volume candidate
SGMO: 17.55 (-0.51)
Biogen's hemophilia B med successful in Phase 3 trial in children
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 8:59AM CST
BIIB: 417.63 (-7.98), ALNY: 107.67 (-3.89), OPK: 14.11 (-0.21), ONCE: 58.01 (+0.48), BAX: 67.73 (-1.48), SHPG: 235.75 (-2.31), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51)
The Top Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sun Feb 22, 2:51AM CST
GFIG: 5.83 (+0.11), MATW: 46.36 (-1.03), RTIX: 5.32 (-0.03), ELLI: 51.40 (-0.66), KFRC: 22.15 (-0.23), SILC: 45.43 (+0.17), SGMO: 17.55 (-0.51), AFFX: 11.81 (-0.38), BABY: 35.54 (-0.45), HBIO: 5.58 (+0.07), EXAM: 39.64 (-0.06), IART: 59.15 (-0.96), UEIC: 55.16 (-0.70), CNMD: 50.44 (-0.98), BJRI: 51.63 (-0.88), NLNK: 48.65 (-0.28), CTRN: 25.74 (-0.47), ANAC: 47.18 (+0.36), CSU: 24.90 (-0.46), RRGB: 78.48 (-3.35), DIOD: 28.32 (+0.06), DEPO: 23.44 (-0.77), DYAX: 15.64 (-0.05), FARO: 53.91 (-2.22), PERY: 22.62 (-0.69), PACB: 6.17 (-0.22), PFPT: 55.39 (-1.50), MTSI: 33.21 (-0.61), IRWD: 15.81 (+0.04), ABAX: 62.39 (+0.24), SCSS: 31.82 (-0.39), ANIP: 66.72 (+0.21), FORM: 9.01 (-0.19), BEAT: 10.31 (-0.33), QLGC: 14.88 (-0.08), PENX: 18.84 (unch), EBIX: 25.17 (-0.20), CORT: 3.42 (-0.19), UTMD: 59.52 (-0.56), DAVE: 31.17 (-0.45), SWHC: 14.23 (-0.17)
Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), CVM: 1.06 (-0.08), MDGN: 8.35 (+0.17), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), RPRX: 9.84 (-0.01), MNKD: 5.47 (-0.26), CELG: 118.03 (-2.68), SGEN: 35.32 (-0.28), TEVA: 56.40 (-0.11), ARIA: 8.08 (-0.17), SNY: 47.42 (-0.94), REGN: 422.13 (-6.82)
Insider Trading Alert - ABMD, CCMP And SGMO Traded By Insiders
at The Street - Thu Feb 19, 10:15AM CST
Stocks with insider trader activity include ABMD, CCMP and SGMO
ABMD: 60.35 (-1.03), SGMO: 17.55 (-0.51), CCMP: 50.13 (-0.58)
Makers of pricey drugs working on new payment model
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 9:10AM CST
ABT: 46.50 (-0.94), BIIB: 417.63 (-7.98), BMRN: 113.77 (+0.27), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), AMGN: 154.88 (-4.72), LLY: 68.41 (-2.18), BMY: 65.12 (-0.93), GSK: 46.73 (-0.87), CELG: 118.03 (-2.68), JNJ: 100.11 (-2.41), QURE: 24.62 (+1.77), GILD: 101.81 (-1.61), BAX: 67.73 (-1.48), MRK: 56.84 (-1.14), AZN: 66.27 (-1.91), NVS: 97.46 (-1.49)
A Look at the Latest Occurrences in the Healthcare Sector: Special Research on Sangamo BioSciences,Seattle Genetics, StemCells, Synageva and VBI Vaccines
PR Newswire - Thu Feb 19, 6:50AM CST
Editor Note: For more information about this release, please scroll to bottom.
GEVA: 103.20 (+1.96), SGEN: 35.32 (-0.28), STEM: 1.23 (-0.06), SGMO: 17.55 (-0.51), VBIV: 2.98 (+0.07)
Sangamo BioSciences - Gene Therapy To Invest In
Samreen Agha - at Seeking Alpha - Wed Feb 18, 11:55AM CST
SGMO: 17.55 (-0.51)
3 Stocks That Were Huge Winners Last Week
Todd Campbell, The Motley Fool - Motley Fool - Sat Feb 14, 11:29AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. The market's best-performing companies last week included...
JNJ: 100.11 (-2.41), BIIB: 417.63 (-7.98), PTLA: 41.72 (-0.13), SHPG: 235.75 (-2.31), PFE: 33.97 (-0.50), SGMO: 17.55 (-0.51), BMY: 65.12 (-0.93), MOH: 61.27 (-1.00)
Sangamo BioSciences Presents Data At 11th Annual WorldSymposium(TM) Meeting Supporting In Vivo Protein Replacement Platform Approach For The Treatment Of Lysosomal Storage Disorders
PR Newswire - Thu Feb 12, 6:00AM CST
Sangamo BioSciences, Inc. (NASDAQ: SGMO) announced the presentation of preclinical data from its In Vivo Protein Replacement Platform (IVPRP) program for the development of proprietary ZFP Therapeutics® for the potential cure of lysosomal storage disorders (LSDs). The study was presented at the WORLDSymposium(TM) 2015 Meeting, a multidisciplinary forum presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases, which is being held in Orlando, Florida, from February 9-13, 2015. The data were generated by Sangamo scientists and their collaborators at the University of Minnesota and University of Massachusetts Medical School.
SGMO: 17.55 (-0.51)
4 Stocks Spiking on Big Volume: Akamai, Hydrogenics and More
at The Street - Wed Feb 11, 1:11PM CST
Unusual volume can also be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
HYGS: 14.82 (+0.04), AKAM: 69.96 (-1.13), SGMO: 17.55 (-0.51), FTI: 38.84 (-0.65)
Why Sangamo Biosciences Inc. Shares Rocketed Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Wed Feb 11, 11:58AM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Sangamo Biosciences shares surged more than 14%...
BIIB: 417.63 (-7.98), SHPG: 235.75 (-2.31), SGMO: 17.55 (-0.51)
Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 11:45AM CST
JIVE: 5.01 (-0.02), JONE: 8.68 (+0.26), FXEN: 1.83 (-0.03), CDTI: 1.98 (-0.02), SGMO: 17.55 (-0.51), EVRY: 1.00 (unch), INXN: 29.87 (-0.21), RLOC: 2.98 (-0.02), ATEN: 4.33 (-0.11), BLDP: 2.29 (-0.06), PNTR: 8.85 (+0.06), PRSS: 3.48 (-0.02), BXE: 2.99 (-0.06), ANTH: 6.12 (+0.59), PIR: 11.96 (-0.09), PSTR: 3.58 (-0.17), MKTO: 26.56 (-0.42), ANDE: 42.11 (-3.25), DGLY: 12.81 (+0.43), DCTH: 1.16 (+0.02)
Sangamo BioSciences ups revenues 117% in Q4
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 7:55AM CST
SGMO: 17.55 (-0.51)
Sangamo Biosciences' (SGMO) CEO Edward Lanphieron Q4 2014Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Feb 10, 6:56PM CST
SGMO: 17.55 (-0.51)
Sangamo BioSciences (SGMO) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Tue Feb 10, 3:55PM CST
SGMO: 17.55 (-0.51)
Sangamo BioSciences beats by $0.03, beats on revenue
Seeking Alpha - at Seeking Alpha - Tue Feb 10, 3:05PM CST
SGMO: 17.55 (-0.51)
Sangamo BioSciences Reports Fourth Quarter and Full Year 2014 Financial Results
PR Newswire - Tue Feb 10, 3:02PM CST
Sangamo BioSciences, Inc. (NASDAQ: SGMO) today reported its fourth quarter and full year 2014 financial results and accomplishments.
SGMO: 17.55 (-0.51)
Notable earnings after Tuesday’s close
Seeking Alpha - at Seeking Alpha - Mon Feb 09, 4:35PM CST
SGMO: 17.55 (-0.51), USNA: 98.80 (-0.77), RLOC: 2.98 (-0.02), ATEN: 4.33 (-0.11), VSAT: 64.50 (-0.25), RPXC: 14.23 (-0.06), TRMB: 26.10 (-0.25), KGC: 2.51 (-0.24), WSH: 47.21 (-0.56), TSRA: 39.92 (+0.26), FTI: 38.84 (-0.65), ACGL: 59.87 (-0.04), LOCK: 13.21 (-0.32), CERN: 69.97 (-2.54), CAP: 23.99 (-0.09), JIVE: 5.01 (-0.02), WU: 19.45 (-0.04), AKAM: 69.96 (-1.13), SKT: 34.13 (-0.92), NCR: 28.77 (-0.39), FRT: 137.11 (-4.74), SCI: 25.21 (-0.07), ELON: 1.16 (-0.01), GNW: 7.67 (+0.06), RKUS: 12.35 (-0.17), GHDX: 32.01 (-0.32), BLKB: 45.07 (-0.09), PXD: 156.17 (-4.27), SGEN: 35.32 (-0.28), OHI: 38.02 (-1.99), THOR: 39.50 (-0.83), MKTO: 26.56 (-0.42), CRL: 76.77 (-0.93), TMH: 57.11 (-1.15), ANDE: 42.11 (-3.25), XOOM: 16.09 (-0.37), HIW: 43.31 (-1.65), PAYC: 32.16 (-0.19)
(0)
(0)